tenecteplase
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
te-nek-te-plase

Trade Name(s)
- TNKase
Ther. Class.
Pharm. Class.
plasminogen activators
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Tenecteplase." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109088/8/tenecteplase.
Vallerand AHA, Sanoski CAC, Quiring CC. Tenecteplase. Davis's Drug Guide. F.A. Davis Company; 2023. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109088/8/tenecteplase. Accessed May 31, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Tenecteplase. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109088/8/tenecteplase
Vallerand AHA, Sanoski CAC, Quiring CC. Tenecteplase [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 May 31]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109088/8/tenecteplase.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - tenecteplase
ID - 109088
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/109088/8/tenecteplase
PB - F.A. Davis Company
ET - 18
DB - Nursing Central
DP - Unbound Medicine
ER -